The Science of Dental Prescribing and Pharmacotherapeutics – From Pharmacokinetics to Clinical Decision-Making – Season Pass #3

Summary:

Date: Friday, March 5, 2027
Time: 8am – 5pm (including lunch hour)
Location: Gibson’s Bar & Steakhouse @ Oak Brook, IL
Speaker: Dr. Steve Shufflebarger
CE Credits: 8 CE Lecture Credits
Tuition: (Breakfast and Lunch Included)
AGD Dentist: $450
Non-AGD Dentist: $550
Hygienist or staff (AGD Dentist): $95
Hygienist or staff (Non-AGD Dentist): $115
Student/Resident: $20

Speaker’s Bio:

For the last 26 years, Dr. Shufflebarger has practiced exclusively in the sedation/anesthesia and surgical aspects of dentistry, at his own practice in Beavercreek, Ohio as well as numerous offices in Dayton, Ohio and surrounding communities. He maintains privileges at 3 local hospitals. After beginning his education at Purdue University studying chemistry, he continued on to The Ohio State University College of Dentistry where he was honored to earn the Horace Wells student award for Outstanding Achievement in the Field of Dental
Anesthesiology. Thereafter he completed a residency program with Miami Valley Hospital. Dr. Shufflebarger has achieved the status of Master of the College of Sedation with the ADSA. Currently, in addition to maintaining his private clinical practice, Dr. Shufflebarger is the Managing Director of Miami Valley Hospital’s Department of Medical Education’s long standing comprehensive Moderate Sedation training series, where he creates didactic, skills and simulation content for sedation training. He has instructor status and trains medical professionals in BLS, ACLS, and PALS. Dr. Shufflebarger has been privileged to speak and teach in settings ranging from national organizations to local dental society meetings, dental schools, residency programs, medical schools, hospitals, regional events and virtual seminars.

Course Description:

This course provides a comprehensive review of essential pharmacokinetic and pharmacodynamic principles that form the scientific foundation for rational analgesic and anti-inflammatory prescribing in dentistry. In-depth coverage includes opioid and non-opioid analgesics, antibiotics, and both steroidal and non-steroidal anti-inflammatory drugs. The course also examines current scientific evidence surrounding recently FDA-approved analgesics with atypical mechanisms of action.

In addition, select non–first-line drug classes commonly prescribed by physicians for pain management will be reviewed to enhance dental practitioners’ clinical decision-making and interdisciplinary understanding.

Special attention is given to substance misuse and abuse, and how these challenges influence patient care and interprofessional collaboration. Local anesthetics are emphasized as both a cornerstone of pain control and a definitive means of addressing the underlying etiology of dental pain.

Additional topics include dependence, tolerance, and addiction, as well as evolving educational, legal, and regulatory prescribing frameworks. Participants will gain practical, evidence-based strategies to improve prescribing practices, enhance patient safety, and optimize clinical outcomes.

This course content fulfills DEA MATE training requirements (8 hours) and satisfies most state opioid prescriber education requirements.

Registration:

Scroll to the bottom to register for this course only.

Sponsored By: